Search Results - "de Jong, Marin J."

Patient-Reported Outcome Measures for Use in Clinical Trials and Clinical Practice in Inflammatory Bowel Diseases: A Systematic Review by de Jong, Marin J., Huibregtse, Roxanne, Masclee, Ad A.M., Jonkers, Daisy M.A.E., Pierik, Marie J.

“…Mucosal inflammation must be carefully monitored to improve the long-term outcomes of patients with inflammatory bowel diseases (IBD). Patient-reported outcome…”
Get full text

Development and Validation of a Patient-reported Score to Screen for Mucosal Inflammation in Inflammatory Bowel Disease by de Jong, Marin J, Roosen, Danielle, Degens, Juliette H R J, van den Heuvel, Tim R A, Romberg-Camps, Marielle, Hameeteman, W, Bodelier, Alexander G L, Romanko, Igor, Lukas, Milan, Winkens, Bjorn, Markus, Tineke, Masclee, Ad A M, van Tubergen, Astrid, Jonkers, Daisy M A E, Pierik, Marie J

“…Abstract Background and Aims Patient-reported outcome measures [PROMs] assessing inflammatory bowel disease [IBD] activity are of interest for monitoring in…”
Get full text

Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomised controlled trial by de Jong, Marin J, van der Meulen-de Jong, Andrea E, Romberg-Camps, Mariëlle J, Becx, Marco C, Maljaars, Jeroen P, Cilissen, Mia, van Bodegraven, Ad A, Mahmmod, Nofel, Markus, Tineke, Hameeteman, Wim M, Dijkstra, Gerard, Masclee, Ad A, Boonen, Annelies, Winkens, Bjorn, van Tubergen, Astrid, Jonkers, Daisy M, Pierik, Marie J

“…Tight and personalised control of inflammatory bowel disease in a traditional setting is challenging because of the disease complexity, high pressure on…”
Get full text

Cost-effectiveness of Telemedicine-directed Specialized vs Standard Care for Patients With Inflammatory Bowel Diseases in a Randomized Trial by de Jong, Marin J., Boonen, Annelies, van der Meulen-de Jong, Andrea E., Romberg-Camps, Mariëlle J., van Bodegraven, Ad A., Mahmmod, Nofel, Markus, Tineke, Dijkstra, Gerard, Winkens, Bjorn, van Tubergen, Astrid, Masclee, Ad, Jonkers, Daisy M., Pierik, Marie J.

“…Telemedicine can be used to monitor determinants and outcomes of patients with chronic diseases, possibly increasing the quality and value of care…”
Get full text

Exploring conditions for redistribution of anti‐tumor necrosis factors to reduce spillage: A study on the quality of anti‐tumor necrosis factor home storage by Jong, Marin J, Pierik, Marieke J, Peters, Andy, Roemers, Mark, Hilhorst, Veronique, Tubergen, Astrid

“…Background and Aim Biologicals are potent drugs for immune‐mediated inflammatory diseases. After discontinuation or switch of therapy, many patients have…”
Get full text

Dientamoeba fragilis and chronic abdominal pain in children: a case–control study by de Jong, Marin J, Korterink, Judith J, Benninga, Marc A, Hilbink, Mirrian, Widdershoven, J, Deckers-Kocken, Judith M

“…Background The association between Dientamoeba (D.) fragilis and the aetiology of functional gastrointestinal disorders (FGID) in children is unclear. Aim The…”
Get full text

Novel Perceived Stress and Life Events Precede Flares of Inflammatory Bowel Disease: A Prospective 12-Month Follow-Up Study by Wintjens, Dion S J, de Jong, Marin J, van der Meulen-de Jong, Andrea E, Romberg-Camps, Mariëlle J, Becx, Marco C, Maljaars, Jeroen P, van Bodegraven, Ad A, Mahmmod, Nofel, Markus, Tineke, Haans, Jeoffrey, Masclee, Ad A M, Winkens, Bjorn, Jonkers, Daisy M A E, Pierik, Marie J

“…Abstract Background and Aims Inflammatory bowel disease [IBD] is characterized by recurrent disease flares. The impact of psychosocial wellbeing on the…”
Get full text

Risk of impaired nutritional status and flare occurrence in IBD outpatients by Spooren, Corinne E.G.M., Wintjens, Dion S.J., de Jong, Marin J., van der Meulen-de Jong, Andrea E., Romberg-Camps, Mariëlle J., Becx, Marco C., Maljaars, Jeroen P., van Bodegraven, Ad A., Mahmmod, Nofel, Markus, Tineke, Hameeteman, Wim M., Masclee, Ad A.M., Winkens, Bjorn, Jonkers, Daisy M.A.E., Pierik, Marie J.

“…Inflammatory bowel disease (IBD) patients are at risk of an impaired nutritional status. The impact thereof on the IBD relapse risk is clinically relevant,…”
Get full text

394 YIELD OF SURVEILLANCE COLONOSCOPY IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS by van de Pol, Natasja, Mol, Bregje, de Jong, Marin J., Weersma, Rinse K., Inderson, Akin, Slooter, Floor C., Gibbes, Livianael A., van der Meer, Adriaan J., Derikx, Lauranne, Ponsioen, Cyriel Y., De Vries, Annemarie C.

Get full text